Article Information
History
- May 9, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew E. Levy1,*,
- Vanessa Chilunda1,
- Richard E. Davis2,
- Phillip R. Heaton3,
- Pamala A. Pawloski4,
- Jason D. Goldman5,6,
- Cynthia A. Schandl7,
- Lisa M. McEwen1,
- Elizabeth T. Cirulli1,
- Dana Wyman1,
- Andrew Dei Rossi1,
- Hang Dai1,
- Magnus Isaksson1,
- Nicole L. Washington1,
- Tracy Basler1,
- Kevin Tsan1,
- Jason Nguyen1,
- Jimmy Ramirez1,
- Efren Sandoval1,
- William Lee1,
- James Lu1 and
- Shishi Luo1
- 1Helix, San Mateo, California, USA
- 2Providence Sacred Heart Medical Center and Children’s Hospital, Spokane, Washington, USA
- 3Department of Pathology and Laboratory Medicine, HealthPartners, Bloomington, Minnesota, USA
- 4HealthPartners Institute, Minneapolis, Minnesota, USA
- 5Swedish Center for Research and Innovation, Providence Swedish Medical Center, Seattle, Washington, USA
- 6Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA
- 7Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
- ↵*Corresponding author:
Matthew Levy, PhD. Helix. Mail: 101 S. Ellsworth Avenue, Suite 350, San Mateo, CA 94401. Email: matt.levy{at}helix.com.
Posted May 09, 2024.
Reduced Likelihood of Hospitalization with the JN.1 or HV.1 SARS-CoV-2 Variants Compared to the EG.5 Variant
